A2M (alpha-2-macroglobulin)

Show full item record

Files in this item

PDF 04-2020-A2MID42923ch12p13.pdf 1.074Mb

Pour citer ce document :
URI: http://hdl.handle.net/2042/70878  |   DOI : https://doi.org/10.4267/2042/70878
Title: A2M (alpha-2-macroglobulin)
Author: Gurbanov, Rafig; Samgane, Gizem
Abstract: Alpha-2-Macroglobulin (A2M) was first recognized as a broad-spectrum protease inhibitor and is a pan-proteinase inhibitor that can mechanistically inhibit all proteinase families. It plays an important role in the clearance of proteinases from circulation, regulation of fibrinolysis, coagulation and complement activation. A2M is also known to act as a transport/carrier protein. In general, A2M is produced by the liver as an acute-phase protein during stress conditions and then secreted into the blood and extracellular environments where it functions. It is also locally produced by macrophages, fibroblasts, and epithelial cells. A2M gene mutations play a role in the pathogenesis of diseases such as Alzheimer's disease, parkinson's disease, and prostate cancer
Subject: Alpha-2-Macroglobulin (A2M); Pan-proteinase inhibitor; Alzheimer Disease; Parkinson's Disease; Genes Section; Alpha-Globulins/*metabolism; Humans; Injections, Intra-Articular; Osteoarthritis, Knee/*therapy; Platelet-Rich Plasma/*chemistry/metabolism; Amyloid beta-Peptides/metabolism; Animals; Humans; Hypochlorous Acid/*metabolism; Immune System/metabolism; Neurodegenerative Diseases/metabolism/pathology; Peptide Hydrolases/metabolism; Pregnancy-Associated alpha 2-Macroglobulins/chemistry/*metabolism
Publisher: ARMGHM - Atlas Génétique des Cancers
Date: 2020

This item appears in the following Collection(s)

Show full item record

Advanced Search